OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
[18F] AlF-NOTA-FAPI-04 PET/CT can predict treatment response and survival in patients receiving chemotherapy for inoperable pancreatic ductal adenocarcinoma
Ziyuan Zhu, Kai Cheng, Yun Zhang, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2023) Vol. 50, Iss. 11, pp. 3425-3438
Closed Access | Times Cited: 12
Ziyuan Zhu, Kai Cheng, Yun Zhang, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2023) Vol. 50, Iss. 11, pp. 3425-3438
Closed Access | Times Cited: 12
Showing 12 citing articles:
Clinical applications of fibroblast activation protein inhibitor positron emission tomography (FAPI-PET)
Yuriko Mori, Emil Novruzov, Dominik Schmitt, et al.
npj Imaging (2024) Vol. 2, Iss. 1
Open Access | Times Cited: 8
Yuriko Mori, Emil Novruzov, Dominik Schmitt, et al.
npj Imaging (2024) Vol. 2, Iss. 1
Open Access | Times Cited: 8
Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma or a Metaphor for Heterogeneity: From Single-Cell Analysis to Whole-Body Imaging
Rita Saúde-Conde, Ayça Arçay, Kosta Stosic, et al.
Biomedicines (2024) Vol. 12, Iss. 3, pp. 591-591
Open Access | Times Cited: 6
Rita Saúde-Conde, Ayça Arçay, Kosta Stosic, et al.
Biomedicines (2024) Vol. 12, Iss. 3, pp. 591-591
Open Access | Times Cited: 6
Evaluating ΔMTV%, ΔDmax%, and %ΔSUVmax of 18F-FDG PET/CT for mid-treatment efficacy and prognosis in diffuse large B-cell lymphoma
Yali Cui, Yao Li, Wenhao Hu, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Yali Cui, Yao Li, Wenhao Hu, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
[18F]FAPI- 04 PET/CT for pathologic response assessment in pancreatic cancer patients with systemic treatment
Xiang Li, Na Lu, Kang Sun, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2025)
Closed Access
Xiang Li, Na Lu, Kang Sun, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2025)
Closed Access
FAP-targeted PET imaging in gastrointestinal malignancies: a comprehensive review
Ayça Arçay, Patrick Flamen
Cancer Imaging (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 9
Ayça Arçay, Patrick Flamen
Cancer Imaging (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 9
A pilot study of [68Ga]Ga-fibroblast activation protein inhibitor-04 PET/CT in renal cell carcinoma
Chunmei Guo, Ya Liu, Haozhou Yang, et al.
British Journal of Radiology (2024) Vol. 97, Iss. 1156, pp. 859-867
Open Access | Times Cited: 2
Chunmei Guo, Ya Liu, Haozhou Yang, et al.
British Journal of Radiology (2024) Vol. 97, Iss. 1156, pp. 859-867
Open Access | Times Cited: 2
68Ga-labeled fibroblast activation protein inhibitor (FAPI) PET/CT for locally advanced or recurrent pancreatic cancer staging and restaging after chemoradiotherapy
Giulia Metzger, Christian Bayerl, Julian M.M. Rogasch, et al.
Theranostics (2024) Vol. 14, Iss. 11, pp. 4184-4197
Open Access | Times Cited: 2
Giulia Metzger, Christian Bayerl, Julian M.M. Rogasch, et al.
Theranostics (2024) Vol. 14, Iss. 11, pp. 4184-4197
Open Access | Times Cited: 2
[18F]AlF-NOTA-FAPI-04 PET/CT for Predicting Pathologic Response of Resectable Esophageal Squamous Cell Carcinoma to Neoadjuvant Camrelizumab and Chemotherapy: A Phase II Clinical Trial
Yinjun Dong, Zhendan Wang, Xinying Hu, et al.
Journal of Nuclear Medicine (2024), pp. jnumed.124.268557-jnumed.124.268557
Closed Access | Times Cited: 2
Yinjun Dong, Zhendan Wang, Xinying Hu, et al.
Journal of Nuclear Medicine (2024), pp. jnumed.124.268557-jnumed.124.268557
Closed Access | Times Cited: 2
Integrated 68Ga-FAPI-04 PET/MR in Pancreatic Cancer
Zeyu Zhang, Shiwei Guo, Chao Cheng, et al.
Clinical Nuclear Medicine (2024)
Closed Access | Times Cited: 1
Zeyu Zhang, Shiwei Guo, Chao Cheng, et al.
Clinical Nuclear Medicine (2024)
Closed Access | Times Cited: 1
Unveiling the Tumor Microenvironment Through Fibroblast Activation Protein Targeting in Diagnostic Nuclear Medicine: A Didactic Review on Biological Rationales and Key Imaging Agents
Juliette Fouillet, Jade Torchio, Léa Rubira, et al.
Biology (2024) Vol. 13, Iss. 12, pp. 967-967
Open Access | Times Cited: 1
Juliette Fouillet, Jade Torchio, Léa Rubira, et al.
Biology (2024) Vol. 13, Iss. 12, pp. 967-967
Open Access | Times Cited: 1
Clinical applications of fibroblast activation protein‐targeted theranostics in oncologic and nononcologic disease: Current status and future directions
Hao Fu, Wei Guo, Jingxiong Huang, et al.
iRadiology (2023) Vol. 1, Iss. 4, pp. 340-361
Open Access | Times Cited: 3
Hao Fu, Wei Guo, Jingxiong Huang, et al.
iRadiology (2023) Vol. 1, Iss. 4, pp. 340-361
Open Access | Times Cited: 3
[68Ga]Ga-FAPI-46 False-Positive Uptake After Chemotherapy in Nonseminomatous Germ Cell Tumor Metastatic Lesions
Vinícius Ludwig, Peter George Maliha, John Paul Shen, et al.
Journal of Nuclear Medicine (2024) Vol. 65, Iss. 8, pp. 1328-1329
Closed Access
Vinícius Ludwig, Peter George Maliha, John Paul Shen, et al.
Journal of Nuclear Medicine (2024) Vol. 65, Iss. 8, pp. 1328-1329
Closed Access
